Jiangsu Hengrui Medicine
600276.SS
#503
Rank
ยฃ32.17 B
Marketcap
ยฃ5.04
Share price
0.39%
Change (1 day)
-0.58%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): ยฃ0.07546

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is ยฃ0.07157. In 2022 the company made an earnings per share (EPS) of ยฃ0.07136 a decrease over its 2021 EPS that were of ยฃ0.08608.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.075465.74%
2022ยฃ0.07136-17.1%
2021ยฃ0.08608-24.44%
2020ยฃ0.1120.3%
2019ยฃ0.0946925.58%
2018ยฃ0.0754027.55%
2017ยฃ0.0591221.64%
2016ยฃ0.0486013.57%
2015ยฃ0.0427939.86%
2014ยฃ0.0306021.33%
2013ยฃ0.0252217.7%
2012ยฃ0.0214325.56%
2011ยฃ0.0170626.22%
2010ยฃ0.0135210.3%
2009ยฃ0.0122657.92%
2008ยฃ0.00776111.06%
2007ยฃ0.00698885.81%
2006ยฃ0.00376187.94%
2005ยฃ0.00200133.97%
2004ยฃ0.00149429.78%
2003ยฃ0.00115119.78%
2002ยฃ0.0009608